Overview: After several attempts, the euro has pushed above $1.22, and the Australian dollar has surpassed $0.8000 as the greenback remains under broad pressure against the...
Allot is in talks with multiple US telecom operators for security deals as COVID-19 has accelerated the demand for network-based protection for the consumer market, CEO...
"Door Is Always Open": China Invites UN Rights Chief To Investigate Uighur Genocide Charge While vehemently rejecting widespread reports from the US and Western allies as well as...
AG Hair could have waited out the pandemic but instead decided to lean into its entrepreneurial culture and make a sharp pivot The post How a...
Montreal’s Lightspeed POS Inc. probably isn’t big enough to be a true bellwether for the economy, but its performance can likely tell us something about the...
A number of central banks responded over the past week to rising bond yields driven higher by reflationary expectations. As a result, the risk that tantrums...
Europe’s drug regulator is evaluating South Korean drugmaker Celltrion’s Covid-19 antibody treatment, the third such drug against the disease to go under real-time review in the...
The TJX Companies 4Q earnings were disappointing as the off-price retailer reported diluted earnings per share (EPS) of $0.27, which fell short of analysts’ estimates of...
We should assess the pandemic’s effect in the round, beyond just COVID deaths.
Overview: The sharp recovery in US shares yesterday that saw the S&P 500 snap a five-day slide failed to carry into Asia Pacific trading earlier today. ...
An online consultation app developed by Livi is already available for around five million patients in the UK The post Livi expands reach for its online...
AstraZeneca has said it will be able meet a target to deliver 180 million COVID-19 vaccines to the EU
HSBC To Slash Office Space By 43% As COVID Ushers In Hybrid Work There is absolutely no way to avoid a great deal of pain coming...
The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company's tick-borne encephalitis vaccine for active immunization to...
The first shipment of Russia’s Sputnik-V COVID jab has arrived in Mexico just days after the Russian government moved to approve a 2nd experimental vaccine
Credit: Alzheimer Europe Luxembourg, 23 February 2021 – At an online European Parliament workshop hosted by Deirdre Clune MEP (Ireland), Alzheimer Europe launched a new report...
The former European Central Bank supremo has been generally seen as a good hire for Italy, but there are also global issues at play.
Overview: Rising rates continue to spur a rotation and retreat in stocks. Yesterday the NASDAQ sold-off by nearly 2.5% while the Dow Industrials eked out a...
Asian equities shrug off Wall Street retreat There is a feeling today in the air of “every man for himself”, with the equity markets diverging in...
Pelosi Orders Capitol Flags Lowered To Half-Mast As US COVID Deaths Top 500K A major morbid COVID milestone, which we first warned about earlier this am,...
US COVID Deaths Near 500K, Biden Plans Candle-Lighting Ceremony To Honor Milestone The US is on the cusp of what some are calling a "once unthinkable"...
Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag
Misinformation isn't an inevitable product of social media. Proven techniques can help tech companies clean up their acts.
Zoetis Inc., an animal health company announced that Solensia, its treatment of osteoarthritis, has been granted marketing authorization from the European Commission. Specifically, Zoetis’ (ZTS) Solensia...
Overview: Higher interest rates, driven by inflation expectations, is forcing an adjustment to equity markets. The S&P 500 is poised to gap lower today following slides...
Just As COVID Vaccine Found To Be 99% Effective In Preventing Death, Japan Discovers New, More Contagious Strain With each passing day, covid gets closer to...
Pharma’s pipeline continues to provide drama as investors look beyond COVID-19...
Shares of Dynavax Technologies Corp. rose about 6% on Feb. 19 after the biopharmaceutical company announced that its hepatitis B vaccine, Heplisav B has received marketing...
Welcome back to This Week in Apps, the weekly TechCrunch series that recaps the latest in mobile OS news, mobile applications and the overall app economy.
Latest Viral Threat: Bubonic Plague Emerges In Congo While the world continues to focus on the COVID-19 pandemic, several other (far more deadly) viruses have made...